Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies

Learn about the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management
Randy J. Seeley, PhD
Jenny Tong, MD, MPH
Kristina M. Utzschneider, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.30 MB
Released: August 18, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novo Nordisk Inc.

Related Content

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on improving care for type 2 diabetes

Carol Hatch Wysham, MD Released: October 7, 2021

Short video from Clinical Care Options (CCO) featuring expert insights on the clinical management of persons with T2D and metabolic comorbidities

Carol Hatch Wysham, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.5 CPEU(s) Released: September 30, 2021 Expired: September 29, 2022

Downloadable slides from Clinical Care Options (CCO) featuring expert insights on individualizing management of patients with T2D and cardiometabolic comorbidities

Carol Hatch Wysham, MD Released: September 30, 2021

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on emerging data on tirzepatide for type 2 diabetes

Carol Hatch Wysham, MD Released: September 21, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue